Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Impact of an Ophthalmic Cooling Device on Corneal Immune and Sensory Nerve Features in Chronic Ocular Surface Pain: A Prospective, Feasibility Study.
Journal: Ophthalmology and therapy
Published: June 01, 2026
Using Lotilaner Ophthalmic Solution, 0.25% to Treat Demodex Blepharitis in Patients Who Were Initially Misdiagnosed: A Case Series.
Journal: Clinical optometry
Published: February 04, 2026
Lotilaner ophthalmic solution 0.25% in the treatment of Demodex blepharitis: A case report.
Journal: SAGE open medical case reports
Published: November 14, 2025
Economics of corneal cross-linking for keratoconus treatment.
Journal: Journal of medical economics
Published: September 22, 2025
International consensuses and guidelines on multifocal intraocular lenses (IOLs) by the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO).
Journal: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
Published: June 17, 2025
The Demodex Expert Panel on Treatment and Eyelid Health (DEPTH) Consensus Regarding the Preferred Treatment for Demodex Blepharitis.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: March 25, 2025
Effectiveness and safety of a novel crosslinked hyaluronate canalicular gel occlusive device for dry eye.
Journal: Journal of cataract and refractive surgery
Published: May 01, 2024
Efficacy and Safety of CSF-1 (0.4% Pilocarpine Hydrochloride) in Presbyopia: Pooled Results of the NEAR Phase 3 Randomized, Clinical Trials.
Journal: Clinical therapeutics
Published: October 10, 2023
0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: May 17, 2023
Delphi Panel Consensus Regarding Current Clinical Practice Management Options for Demodex blepharitis.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: December 03, 2022
Phase 2, Randomized, Open-Label Parallel-Group Study of Two Dosing Regimens of Netarsudil for the Treatment of Corneal Edema Due to Fuchs Corneal Dystrophy.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: November 03, 2022
Last Updated: 09/26/2026